Some directors and senior executives of Changhong Huayi Compressor (000404.SZ) plan to increase their holdings by no less than 3.3583 million yuan.
Changhong Huayi (000404.SZ) announced that some directors and senior management plan to increase their holdings of the company's shares through centralized bidding trading on the open market within 3.5 months from the disclosure date of the announcement, with a total increase of no less than 3.3583 million yuan (including principal).
Changhong Huayi Compressor (000404.SZ) announced that some directors and senior management personnel of the company plan to increase their holdings of the company's shares through centralized bidding transactions on the public market within 3.5 months from the date of the announcement, with a total increase amount not less than 3.3583 million yuan (including the principal amount).
Related Articles

INNOGEN-B(02591): The clinical trial application for the new veterinary drug Isubpagrulupeptide has been accepted.

The additional share purchase rights (02675) of EDGE MEDICAL-B have been exercised, marking the end of the stable price period.

US Stock Market Move | 2026 performance guidance greatly exceeds expectations, Eli Lilly (LLY.US) rises over 8% in pre-market trading.
INNOGEN-B(02591): The clinical trial application for the new veterinary drug Isubpagrulupeptide has been accepted.

The additional share purchase rights (02675) of EDGE MEDICAL-B have been exercised, marking the end of the stable price period.

US Stock Market Move | 2026 performance guidance greatly exceeds expectations, Eli Lilly (LLY.US) rises over 8% in pre-market trading.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


